These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27871448)

  • 1. Diagnostic and prognostic value of serum vitronectin levels in human glioma.
    Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL
    J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.
    Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL
    Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
    Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
    Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.
    Chen XY; Chen JY; Chen Y; Chen JF; Lin N; Ding CY; Kang DZ; Wang DL; Fang WH
    Clin Neurol Neurosurg; 2021 Oct; 209():106912. PubMed ID: 34509141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF2 as a potential prognostic biomarker for proneural glioma patients.
    Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
    Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.
    Liu ZY; Tang F; Wang J; Yang JZ; Chen X; Wang ZF; Li ZQ
    BMC Cancer; 2024 Jun; 24(1):692. PubMed ID: 38844902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
    Strojnik T; Smigoc T; Lah TT
    Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
    Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
    Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
    Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
    Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas.
    He ZQ; Duan H; Ke C; Zhang XH; Guo CC; Al-Nahari F; Zhang J; Chen ZH; Chen YS; Liu ZG; Wang J; Chen ZP; Jiang XB; Mou YG
    Oncotarget; 2017 Jul; 8(30):49605-49614. PubMed ID: 28548947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma.
    Wang T; Niu X; Gao T; Zhao L; Li J; Gan Y; Liu Y; Mao Q
    World Neurosurg; 2018 Apr; 112():e269-e277. PubMed ID: 29337167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.